abstract |
The present invention provides mouse farnesoid X receptor (FXR) polynucleotides and polypeptides, as well as expression vectors and host cells for expression of mouse FXR. Also provided are methods for screening for modulators of mouse FXR and methods for using these modulators for the treatment of FXR-related diseases. |